rs34377097
Positions:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001060.6(TBXA2R):c.179G>T(p.Arg60Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000134 in 1,612,836 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00014 ( 4 hom. )
Consequence
TBXA2R
NM_001060.6 missense
NM_001060.6 missense
Scores
1
9
9
Clinical Significance
Conservation
PhyloP100: 1.15
Genes affected
TBXA2R (HGNC:11608): (thromboxane A2 receptor) This gene encodes a member of the G protein-coupled receptor family. The protein interacts with thromboxane A2 to induce platelet aggregation and regulate hemostasis. A mutation in this gene results in a bleeding disorder. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.06575355).
BP6
Variant 19-3600456-C-A is Benign according to our data. Variant chr19-3600456-C-A is described in ClinVar as [Benign]. Clinvar id is 12712.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 8 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBXA2R | NM_001060.6 | c.179G>T | p.Arg60Leu | missense_variant | 2/3 | ENST00000375190.10 | NP_001051.1 | |
TBXA2R | NM_201636.3 | c.179G>T | p.Arg60Leu | missense_variant | 2/4 | NP_963998.2 | ||
TBXA2R | XM_011528214.3 | c.179G>T | p.Arg60Leu | missense_variant | 3/4 | XP_011526516.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBXA2R | ENST00000375190.10 | c.179G>T | p.Arg60Leu | missense_variant | 2/3 | 1 | NM_001060.6 | ENSP00000364336.4 | ||
TBXA2R | ENST00000589966.1 | c.179G>T | p.Arg60Leu | missense_variant | 1/2 | 1 | ENSP00000468145.1 | |||
TBXA2R | ENST00000411851.3 | c.179G>T | p.Arg60Leu | missense_variant | 2/4 | 2 | ENSP00000393333.2 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152162Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
9
AN:
152162
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000576 AC: 14AN: 243186Hom.: 0 AF XY: 0.0000451 AC XY: 6AN XY: 133082
GnomAD3 exomes
AF:
AC:
14
AN:
243186
Hom.:
AF XY:
AC XY:
6
AN XY:
133082
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000142 AC: 208AN: 1460556Hom.: 4 Cov.: 33 AF XY: 0.000133 AC XY: 97AN XY: 726628
GnomAD4 exome
AF:
AC:
208
AN:
1460556
Hom.:
Cov.:
33
AF XY:
AC XY:
97
AN XY:
726628
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152280Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74464
GnomAD4 genome
AF:
AC:
8
AN:
152280
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
8
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Pathogenic:1Benign:1Other:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Bleeding disorder, platelet-type, 13, susceptibility to Benign:1Other:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
risk factor, no assertion criteria provided | literature only | OMIM | Feb 15, 1996 | - - |
Asthma Pathogenic:1
Likely risk allele, no assertion criteria provided | case-control | Allergology and Ecology Laboratory, University of Burdwan | Nov 04, 2022 | STRING analysis showed that TBXA2R are involved in interaction with different known and predicted Gq proteins (guanine nucleotide-binding G protein, subunits alpha, group q). Out of all Gq proteins, GNA11 acts as an activator of phospholipase C (PLC). PLC hydrolyses phosphoinositides into the two stimulatory second messengers - inositol 1,4,5-triphosphate (IP3) and diacylglycerol. IP3 enhances cytoplasmic free calcium level and diacylglycerol (DAG) activates protein kinase C (PKC). Activated protein kinase C either directly phosphorylates LTC4 synthase enzyme and inactivates it or this regulation may involve another regulatory protein which is yet to be discovered. Inactivation of LTC4 synthase leads to reduction of Leukotriene C4 (LTC4) biosynthesis in platelets. However, in the case of risk allele rs34377097 T-bearing individuals, the non-synonymous polymorphism (R60L) in TBXA2R protein inhibits the interaction between GNA11 and TBXA2R due to the change in the positive charge potentiality at the cytoplasmic domain. This is in line with Hirata et al. 1996, who demonstrated that the R60L polymorphism significantly reduces PLC activity. That leads to simultaneous inactivation of PKC which ultimately results in LTC4 synthase enzyme activation. Activation of this enzyme leads to LTA4 to LTC4 conversion which results in acute asthmatic response including broncho-constriction, tracheolar constriction and increased mucus secretion. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;M
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;.;D
REVEL
Uncertain
Sift
Uncertain
D;.;D
Sift4G
Uncertain
D;D;D
Polyphen
D;.;.
Vest4
MVP
MPC
1.9
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at